latest update:
[TrialBase DB]

trial summary · NCT07413744

The Gut - PRO Study

Probiotic Supplementation Safety and Feasibility Study in Preclinical Alzheimer's Disease

Trial record from the TrialBase DB dataset, status RECRUITING, condition Alzheimer Disease, sponsored by University of Wisconsin, Madison. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07413744phase PHASE1enrollment 40start 2026-11

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The purpose of this study is to assess the safety and feasibility of an oral probiotic supplement (PS) intervention in individuals with dementia or mild-cognitive impairment (MCI) due to Alzheimer's disease or at risk of dementia due to Alzheimer's disease (AD). 40 participants will be enrolled and can expect to be on study for up to 1 year.

Source record: https://clinicaltrials.gov/study/NCT07413744

Facts

registry idNCT07413744
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE1
study typeINTERVENTIONAL
lead conditionAlzheimer Disease
sponsorUniversity of Wisconsin, Madison
sponsor classOTHER
enrollment40
start date2026-11
primary completion2029-09
completion2029-09
results postednot reported

Conditions

  • Alzheimer Disease

Interventions

  • Probiotic
  • Placebo

Countries

  • United States

Intervention types: DRUG, OTHER

Work with this record